*Some Market data delayed by 15 mins.

Insmed, Inc.

Symbol: INSM (NASDAQ)
64.60 ▲ (1.07%) 0.684

Company Description:
Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The company's earlier-stage clinical pipeline includes Brensocatib, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases; and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for pulmonary arterial hypertension.

Key Stats
  • Today's Open: $62.99
  • Today's High: $64.913
  • Today's Low: $61.035
  • Today's Volume: 1.95M
  • Yesterday Close: $63.92
  • Yesterday High: $64.005
  • Yesterday Low: $60.84
  • Yesterday Volume: 3.26M
  • Last Min Volume: 3.21K
  • Last Min High: $64.609
  • Last Min Low: $64.555
  • Last Min VWAP: $64.57067
Company Profile
  • Name: Insmed, Inc.
  • Website: https://www.insmed.com
  • Listed Date: 2000-06-01
  • Location: BRIDGEWATER, NJ
  • Market Status: Active
  • CIK Number: 0001104506
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $10.55B
  • Round Lot: 100
  • Outstanding Shares: 163.12M
  • Asset Type: CS
RECENT FILINGS FOR INSM
Filing DateFiling TypeFormat
2024-06-138-KView
2024-06-124View
2024-06-054View
2024-06-048-KView
2024-06-03144View
2024-05-304View
2024-05-304View
2024-05-304View
2024-05-304View
2024-05-304View
2024-05-308-KView
2024-05-30144View
2024-05-30424B5View
2024-05-29424B5View
2024-05-28144View
2024-05-28144View
2024-05-28144View
2024-05-28144View
2024-05-28144View
2024-05-28144View
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.